GEP201706749B - Vortioxetine manufacturing process - Google Patents

Vortioxetine manufacturing process

Info

Publication number
GEP201706749B
GEP201706749B GEAP201413919A GEAP2014013919A GEP201706749B GE P201706749 B GEP201706749 B GE P201706749B GE AP201413919 A GEAP201413919 A GE AP201413919A GE AP2014013919 A GEAP2014013919 A GE AP2014013919A GE P201706749 B GEP201706749 B GE P201706749B
Authority
GE
Georgia
Prior art keywords
vortioxetine
manufacturing process
dimethyl
decomplexation
thiophenolate
Prior art date
Application number
GEAP201413919A
Other languages
English (en)
Inventor
Thomas Ruhland
Kim Lasse Christensen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of GEP201706749B publication Critical patent/GEP201706749B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02Iron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
GEAP201413919A 2013-02-22 2014-02-20 Vortioxetine manufacturing process GEP201706749B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA201300104 2013-02-22

Publications (1)

Publication Number Publication Date
GEP201706749B true GEP201706749B (en) 2017-10-10

Family

ID=59215387

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201413919A GEP201706749B (en) 2013-02-22 2014-02-20 Vortioxetine manufacturing process

Country Status (37)

Country Link
US (1) US9353073B2 (enExample)
EP (1) EP2958903B1 (enExample)
JP (1) JP6464098B2 (enExample)
KR (1) KR102230628B1 (enExample)
CN (1) CN104995181B (enExample)
AP (1) AP2015008640A0 (enExample)
AU (1) AU2014220735B2 (enExample)
BR (1) BR112015019268B1 (enExample)
CA (1) CA2901821A1 (enExample)
CL (1) CL2015002309A1 (enExample)
CR (1) CR20150423A (enExample)
CY (1) CY1118883T1 (enExample)
DK (1) DK2958903T3 (enExample)
DO (1) DOP2015000187A (enExample)
EA (1) EA027756B1 (enExample)
ES (1) ES2625380T3 (enExample)
GE (1) GEP201706749B (enExample)
HR (1) HRP20170607T1 (enExample)
IL (1) IL240501B (enExample)
LT (1) LT2958903T (enExample)
MA (1) MA38338B1 (enExample)
ME (1) ME02671B (enExample)
MX (1) MX362355B (enExample)
MY (1) MY172337A (enExample)
PE (1) PE20151589A1 (enExample)
PH (1) PH12015501807B1 (enExample)
PL (1) PL2958903T3 (enExample)
PT (1) PT2958903T (enExample)
RS (1) RS55932B1 (enExample)
RU (1) RU2652265C2 (enExample)
SG (1) SG11201506651SA (enExample)
SI (1) SI2958903T1 (enExample)
SM (1) SMT201700238T1 (enExample)
TN (1) TN2015000335A1 (enExample)
UA (1) UA116236C2 (enExample)
WO (1) WO2014128207A1 (enExample)
ZA (1) ZA201506050B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3311666T1 (sl) 2010-08-18 2021-09-30 Biosplice Therapeutics, Inc. Diketoni in hidroksiketoni, kot aktivatorji signalne poti katenina
PL2968249T3 (pl) 2013-02-22 2019-06-28 Samumed, Llc Gamma-diketony jako aktywatory szlaku sygnałowego Wnt/beta-kateniny
RS59797B1 (sr) 2014-08-20 2020-02-28 Samumed Llc Gama-diketoni za tretman i prevenciju starenja kože i bora
WO2016125191A2 (en) 2015-02-04 2016-08-11 Mylan Laboratories Limited Processes for the preparation of vortioxetine hydrobromide
EP3274330A1 (en) 2015-03-26 2018-01-31 Cipla Limited Method for making serotonin reuptake inhibitors
CN106279065A (zh) * 2015-05-12 2017-01-04 北京深蓝海生物医药科技有限公司 一种氢溴酸沃替西汀的精制转晶方法
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
EP3414231B1 (en) * 2016-02-08 2020-08-19 H. Lundbeck A/S Synthesis of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine
MA45532A (fr) 2016-07-01 2019-05-08 H Lundbeck As Schémas posologiques de la vortioxétine destinés à une apparition rapide de l'effet antidépresseur
US10519121B2 (en) 2016-12-30 2019-12-31 Apicore Us Llc Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts
WO2020087031A1 (en) 2018-10-26 2020-04-30 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN109912538B (zh) * 2019-01-22 2021-03-12 安徽赛乐普制药有限公司 一种抗抑郁药沃替西汀的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
DE60219521T2 (de) * 2001-12-20 2007-08-16 H. Lundbeck A/S Aryloxyphenyl und arylsulfanylphenylderivate
BR122020011920A2 (pt) * 2006-06-16 2020-08-25 Lundbeck & Co As H composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto
TW201033181A (en) * 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine

Also Published As

Publication number Publication date
CN104995181A (zh) 2015-10-21
AU2014220735A1 (en) 2015-08-20
BR112015019268A2 (pt) 2020-01-28
RU2015134407A (ru) 2017-03-28
MX2015010656A (es) 2015-12-17
CR20150423A (es) 2015-10-20
MA38338A1 (fr) 2016-09-30
UA116236C2 (uk) 2018-02-26
MA38338B1 (fr) 2018-10-31
JP2016509042A (ja) 2016-03-24
HK1216098A1 (en) 2016-10-14
LT2958903T (lt) 2017-08-25
AP2015008640A0 (en) 2015-08-31
SG11201506651SA (en) 2015-09-29
JP6464098B2 (ja) 2019-02-06
WO2014128207A1 (en) 2014-08-28
HRP20170607T1 (hr) 2017-06-30
EA027756B1 (ru) 2017-08-31
MX362355B (es) 2019-01-14
US20160009670A1 (en) 2016-01-14
KR20150118146A (ko) 2015-10-21
PL2958903T3 (pl) 2017-08-31
PH12015501807B1 (en) 2019-05-31
PT2958903T (pt) 2017-05-26
IL240501A0 (en) 2015-09-24
ME02671B (me) 2017-06-20
ZA201506050B (en) 2017-08-30
AU2014220735B2 (en) 2017-06-22
CL2015002309A1 (es) 2016-03-04
SI2958903T1 (sl) 2017-09-29
EP2958903A1 (en) 2015-12-30
BR112015019268B1 (pt) 2023-01-10
PE20151589A1 (es) 2015-12-03
KR102230628B1 (ko) 2021-03-22
CA2901821A1 (en) 2014-08-28
CY1118883T1 (el) 2018-01-10
IL240501B (en) 2018-08-30
RU2652265C2 (ru) 2018-04-27
PH12015501807A1 (en) 2015-11-09
DOP2015000187A (es) 2015-11-30
ES2625380T3 (es) 2017-07-19
TN2015000335A1 (en) 2017-01-03
US9353073B2 (en) 2016-05-31
DK2958903T3 (en) 2017-05-15
SMT201700238T1 (it) 2017-07-18
CN104995181B (zh) 2017-03-08
MY172337A (en) 2019-11-21
EP2958903B1 (en) 2017-04-12
EA201591349A1 (ru) 2015-12-30
RS55932B1 (sr) 2017-09-29

Similar Documents

Publication Publication Date Title
GEP201706749B (en) Vortioxetine manufacturing process
IN2014MN02496A (enExample)
GEP20217223B (en) Prodrugs of pyridone amides useful as modulators of sodium channels
NZ711326A (en) A process for sodium salt of (2s, 5r)-2-carboxamido-7-oxo-6-sulfooxy -1,6-diaza-bicyclo[3.2.1]octane
NZ711192A (en) Process for making benzoxazepin compounds
NZ711343A (en) Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation
IN2014DN00144A (enExample)
BR112015029399A2 (pt) produção em etapa única de uma composição de polipropileno
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
MX2016007340A (es) Formulacion de biomasa.
WO2014087208A3 (en) A process of preparing alcaftadine
MY174153A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
MX2016006807A (es) Derivados de imidazol.
EA201590594A1 (ru) Макролидные производные, их получение и их терапевтическое использование
EA027831B9 (ru) СПОСОБ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ СОСТОЯНИЙ С ПРИМЕНЕНИЕМ S-[4-(3-ФТОР-3-МЕТИЛБУТИРИЛОКСИ)БУТ-2-ИНИЛ]6α,9α-ДИФТОР-17α-(ФУРАН-2-ИЛ)КАРБОНИЛОКСИ-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОАТА
EA201490019A1 (ru) Способ получения производных имидазола
PH12015501840A1 (en) Production method of pyridazinone compounds
IN2013MU03909A (enExample)
JO3276B1 (ar) طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا.
MX2014012822A (es) Proceso para elaborar derivados de naftiridina.
MX2015017747A (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
IN2014DN07498A (enExample)
MX361673B (es) Procedimiento para la preparación de intermediarios de ácido borónico.
MY161361A (en) Substituted phenyl compounds